Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay.
Scientific Reports
Nepomuceno, Thales C TC; Dos Santos, Ana P P APP; Fernandes, Vanessa C VC; Elias, Anna B R ABR; Gomes, Thiago T TT; Suarez-Kurtz, Guilherme G; Iversen, Edwin S ES; Couch, Fergus J FJ; Monteiro, Alvaro N A ANA; Carvalho, Marcelo A MA
An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
Npj Genomic Medicine
Iversen, Edwin S ES; Lipton, Gary G; Hart, Steven N SN; Lee, Kun Y KY; Hu, Chunling C; Polley, Eric C EC; Pesaran, Tina T; Yussuf, Amal A; LaDuca, Holly H; Chao, Elizabeth E; Karam, Rachid R; Goldgar, David E DE; Couch, Fergus J FJ; Monteiro, Alvaro N A ANA
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Hart, Steven N SN; Hoskin, Tanya T; Shimelis, Hermela H; Moore, Raymond M RM; Feng, Bingjian B; Thomas, Abigail A; Lindor, Noralane M NM; Polley, Eric C EC; Goldgar, David E DE; Iversen, Edwin E; Monteiro, Alvaro N A ANA; Suman, Vera J VJ; Couch, Fergus J FJ
A guide for functional analysis of BRCA1 variants of uncertain significance.
Human Mutation
Millot, Gaël A GA; Carvalho, Marcelo A MA; Caputo, Sandrine M SM; Vreeswijk, Maaike P G MP; Brown, Melissa A MA; Webb, Michelle M; Rouleau, Etienne E; Neuhausen, Susan L SL; Hansen, Thomas v O Tv; Galli, Alvaro A; Brandão, Rita D RD; Blok, Marinus J MJ; Velkova, Aneliya A; Couch, Fergus J FJ; Monteiro, Alvaro N A AN; ,
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.
Nature Medicine
Johnson, Neil N; Li, Yu-Chen YC; Walton, Zandra E ZE; Cheng, Katherine A KA; Li, Danan D; Rodig, Scott J SJ; Moreau, Lisa A LA; Unitt, Christine C; Bronson, Roderick T RT; Thomas, Huw D HD; Newell, David R DR; D'Andrea, Alan D AD; Curtin, Nicola J NJ; Wong, Kwok-Kin KK; Shapiro, Geoffrey I GI
Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.
Molecular Cell
Johnson, Neil N; Cai, Dongpo D; Kennedy, Richard D RD; Pathania, Shailja S; Arora, Mansi M; Li, Yu-Chen YC; D'Andrea, Alan D AD; Parvin, Jeffrey D JD; Shapiro, Geoffrey I GI